Press Release Oct 29 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report for its Baddi manufacturing facility. The report indicates that the facility was classified as Voluntary Action Indicated following an inspection by the USFDA. This disclosure is made in accordance with regulatory requirements for transparency to investors and exchange members.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Oct 24 2025
- Press Release Oct 06 2025
- Press Release Oct 01 2025
- Press Release Sep 23 2025
- Press Release Sep 21 2025
Later from Zydus Lifesciences
- Press Release Nov 04 2025
- Press Release Nov 05 2025
- Press Release Nov 06 2025
- Press Release Nov 07 2025
- Zydus Lifesciences Limited Press Release Nov 11 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences